Tertiary lymphoid structures in pancreatic cancer: molecular mechanisms, heterogeneity, and clinical significance.
Identifying tertiary lymphoid structures in pancreatic cancer opens new avenues for enhancing immunotherapy effectiveness in this notoriously resistant tumor.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal solid tumors and is largely refractory to current immunotherapy. The record is retained for conservative triage based on its relevance and observational cohort study.
What the study was
- Study design
- Observational cohort study
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Biochim Biophys Acta Rev Cancer
Why it surfaced
Retained as a observational cohort study relevant to Novel therapeutics; scoring is conservative from PubMed metadata and abstract only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.